1.01 Функциональная анатомия, тонкая структура и основы патологии сосудов сетчатки

Литература (продолжение)

1. 12. Gardner TW, Antonetti DA, et al. (2000) New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther 2(4):601–608
2. 13. Garner A, Ashton N (1979) Pathogenesis of hypertensive retinopathy: a review. J R Soc Med 72(5):362–365
3. 14. Grunwald JE, Riva CE, et al. (1984) Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 91(12):1447–1452
4. 15. Janzer RC, Raff MC (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325(6101):253–257
5. 16. Kohner EM, Henkind P (1970) Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69(3):403–414
6. 17. Kohner EM, Patel V, et al. (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44(6):603–607
7. 18. Ljubimov AV, Burgeson RE, et al. (1996) Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 44(12):1469–1479
8. 19. Gardiner TA, Archer DB, Curtis TM, Stitt AW (2007) Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation 14(1):25–38
9. 20. Minshall RD, Sessa WC, et al. (2003) Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285(6):L1179–1183
10. 21. Mizutani M, Kern TS, et al. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97(12):2883–2890
11. 22. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y (2003) TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 93(9):829–38
12. 23. Nomura M, Yamagishi S, et al. (1995) Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270(47):28316–28324
13. 24. Padayatti PS, Jiang C, et al. (2001) High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr Eye Res 23(2):106–115
14. 25. Pierce EA, Avery RL, et al. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92(3):905–909
15. 26. Polska E, Polak K, et al. (2004) Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol 88(4):533–537
16. 27. Provis JM (2001) Development of the primate retinal vasculature. Prog Retin Eye Res 20(6):799–821
17. 28. Roy S, Maiello M, et al. (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 93(1):438–442
18. 29. Saint-Geniez M, D'Amore PA (2004) Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 48(8–9):1045–1058
19. 30. Schmetterer L, Wolzt M (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42(4):387–405
20. 31. Sharma NK, Gardiner TA, et al. (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100(1):51–60
21. 32. Stitt AW, Anderson HR, et al. (1994) Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol 78(2):133–137
22. 33. Stitt AW, Gardiner TA, et al. (1995) Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 79(4):362–367
23. 34. Stitt AW, Gardiner TA, et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51(9):2826–2832
24. 35. Stitt AW, Hughes SJ, et al. (2004) Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 47(10):1735–1746
25. 36. Stone J, Itin A, et al. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15(7):4738–4747
26. 37. Tzekov R, Arden GB (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44(1):53–60
27. 38. vom Hagen F, Feng Y, et al. (2005) Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes 113(10):573–576
28. 39. Wong TY, McIntosh R (2005) Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73–74:57–70
29. 40. Yanoff M (1966) Diabetic retinopathy. N Engl J Med 274(24):1344–1349
30. 41. Yanoff M (1969) Ocular pathology of diabetes mellitus. Am J Ophthalmol 67(1):21–38